BioMérieux S.A.
BIM
株式のランク
#1822
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
株価
$97.76
時価総額
$11.51B
変化（1日）
0.93%
変化（1年）
-25.96%
国
FR
取引 BioMérieux S.A. (BIM)
カテゴリー
Healthcare
BioMérieux S.A.（BIM）の株価履歴
終値の最高値: $98.22 （2026-10-01）
終値の最安値: $0.47 （2002-01-01）
終値の最安値: $0.47 （2002-01-01）
BioMérieux S.A. の株価履歴（2002 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | -18.12% |
| 2025 | 19.87% |
| 2024 | -3.27% |
| 2023 | 5.35% |
| 2022 | -25.68% |
| 2021 | -2.88% |
| 2020 | 58.83% |
| 2019 | 32.64% |
| 2018 | -22.37% |
| 2017 | 80.30% |
| 2016 | 23.79% |
| 2015 | 11.80% |
| 2014 | 2.43% |
| 2013 | 10.36% |
| 2012 | 25.01% |
| 2011 | -23.88% |
| 2010 | -18.81% |
| 2009 | 50.69% |
| 2008 | -29.44% |
| 2007 | 68.49% |
| 2006 | 33.52% |
| 2005 | 27.00% |
| 2004 | 105,745.40% |
| 2003 | -98.59% |
| 2002 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
